Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or MDS
NCT00075010Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2004
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML), sponsored by University of Texas MD Anderson Cancer Center. Started Jan 2004; status: completed.
02
Drugs
valproic acid
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)myelodysplastic syndrome (MDS)chronic lymphocytic leukemia (CLL)chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00075010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075010.